Podcast 10: Drug Development in Wake of COVID-19

 

May 1, 2020

In this podcast, we feature an article that examines the effect of COVID-19 on drug development, clinical trials, regulatory review, and new drug approvals.  For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

  • Drug development and regulatory review
  • FDA’s perspective
  • New drug approvals thus far in 2020
  • Clinical trials and COVID-19: where the impact resides
  • Companies adjust clinical-trial research strategies

Sponsor: CordenPharma